We investigated whether the urinary albumin/creatinine ratio (UACR), a measure of albuminuria, is associated with non-invasive measures of arterial function in hypertensive adults without known coronary heart disease (CHD) or stroke. UACR was measured in the first voided morning urine sample in 469 non-Hispanic white hypertensive individuals (mean age 62.279.8 years, 41% men) belonging to hypertensive sibships. High-resolution ultrasonography of the brachial artery was used to assess flow-mediated dilatation (FMD) -an endothelium-dependent response -and nitroglycerin-mediated dilatation (NMD) -an endothelium-independent response. Because of skewed distribution, UACR was log transformed after addition of 0.1. The association of log (UACR þ 0.1) with FMD and NMD, before and after adjustment for CHD risk factors, serum creatinine, and hypertension medication and statin use was assessed using linear regression analyses. In univariable analyses, variables associated with lower FMD were greater age, male sex, history of smoking, lower high-density lipoprotein (HDL) cholesterol, higher serum creatinine and higher log (UACR þ 0.1); variables associated with lower NMD were greater age, male sex, higher systolic blood pressure, lower HDL cholesterol, higher serum creatinine and higher log (UACR þ 0.1). In separate stepwise multivariable regression analyses that adjusted for conventional CHD risk factors, serum creatinine and hypertension medication and statin use, higher log (UACR þ 0.1) was associated with lower brachial artery FMD (P ¼ 0.035) and NMD (P ¼ 0.0002). These findings highlight the association of increased urinary albumin excretion with impaired vascular reactivity in hypertensive individuals.
Introduction
Microalbuminuria (defined as urinary albumin excretion of 30-300 mg/24 h or 20-200 mg/min) 1 in patients with essential hypertension is a precursor to decline in renal function 2 and is also associated with target organ damage 3, 4 and increased risk of adverse cardiovascular (CV) events. [5] [6] [7] Recently, even a mild increase in urinary albumin excretion below the cutoff for microalbuminuria has been found to be associated with increased incidence of adverse CV events. 8, 9 Furthermore, a reduction in albumin excretion with antihypertensive medication is accompanied by a decrease in CV risk. 10 These findings highlight increased urinary albumin excretion as a marker of CV risk.
However, the pathophysiological basis for the association of urinary albumin excretion with CV risk is not fully understood. Endothelial dysfunction, an early event in the pathogenesis of atherosclerosis, has been proposed as the link between urinary albumin excretion and the risk of CV disease. Increased urinary albumin excretion in hypertensive individuals may be a manifestation of endothelial dysfunction in the renal arterial bed as part of a generalized vascular dysfunction. 11 However, correlative studies in this regard are difficult because direct assessment of renal endothelial function generally requires invasive procedures, and assessment of renovascular response to systemically administered endothelial agonists is cumbersome and may be confounded by extra-renal haemodynamic effects of such agents.
We therefore sought to investigate the relationship between urinary albumin excretion and measures of arterial function in hypertensive patients. We hypothesized that increased urinary albumin excretion in hypertensive patients is associated with systemic vascular dysfunction, thereby offering a potential mechanism for increased CV risk associated with albuminuria. To test this hypothesis, we used high-resolution ultrasonography of the brachial artery for non-invasive assessment of endothelial function. 12 Brachial artery flow-mediated dilatation (FMD) has been shown to correlate with 'endothelium-dependent' arterial reactivity in other arterial beds and is therefore considered a bioassay for systemic endothelial function. 12, 13 We also assessed 'endothelium-independent' vasodilatation of the brachial artery by the response to sublingual nitroglycerin -a directly acting vasodilator.
Materials and methods

Study population
Subjects included participants in the Genetic Epidemiology Network of Arteriopathy (GENOA) study, a multicentre community-based study of hypertensive sibships aiming to identify genes influencing blood pressure (BP) levels and the development of target organ damage caused by hypertension. 14 Recruitment and subject characteristics in Phase I 15 and Phase II 16 of the GENOA study have been previously described. All the participants for the present study were non-Hispanic white subjects residing in Olmsted County, MN, USA. Between September 2002 and December 2005, 599 of the Phase II GENOA participants returned for a study visit to undergo arterial function testing. We excluded 78 subjects with a history of stroke, myocardial infarction or coronary revascularization, one participant with macroalbuminuria (UACR 4300 mg/g), one subject with atrial fibrillation and 50 participants with incomplete data. The final study group consisted of 469 individuals (190 men and 279 women). The study was approved by the Institutional Review Board of Mayo Clinic, Rochester MN, USA. Written informed consent was obtained from each participant.
Height was measured by stadiometer, weight by electronic balance and body mass index (BMI) was calculated as weight in kilograms divided by the square of height in metres. Resting systolic blood pressure (SBP) and diastolic blood pressure were measured by random zero sphygmomanometer. The diagnosis of hypertension was established based on BP levels measured at the study visit (X140/90 mm Hg) or a prior diagnosis of hypertension and current treatment with antihypertensive medications. Diabetes was considered present if the subject was being treated with insulin or oral agents or had a fasting glucose level X126 mg/dl. 'Ever' smoking was defined as having smoked more than 100 cigarettes. Information about the use of hypertension medications, statins and oestrogen was obtained from the participants at the time of the study visit. Blood samples were obtained by venipuncture after an overnight fast. Standard enzymatic methods were used to measure total cholesterol, high-density lipoprotein (HDL) cholesterol, plasma glucose and serum creatinine on a Hitachi 911 Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN, USA). Glomerular filtration rate (GFR) was estimated using an equation from the Modification of Diet in Renal Disease (MDRD) Study. 17 
Urinary albumin
The first voided urine was collected on the morning of the study visit and stored at À201C until analysed. Urine albumin, total protein and creatinine concentrations were measured by standard methods on a Hitachi 911 Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN, USA). 18 Urinary albumin excretion was expressed in terms of urinary albumin/creatinine ratio (UACR, mg/g). Spot UACR correlates well with urinary albumin excretion 19 and is commonly used in large epidemiological studies.
Brachial artery reactivity testing
Non-invasive assessment of brachial artery reactivity was performed a median of 28.2 months (mean7s.d., 21.8717.8 months) after measurement of UACR. In accordance with the guidelines of the International Brachial Artery Reactivity Task Force, 20 subjects were studied in the morning after an overnight fast and at least 12 h after taking any medications, using a 10 MHz linear array ultrasound transducer (Acuson Sequoia, Mountain View, CA, USA). After a brief period of rest in a temperaturecontrolled room, each subject was examined in the supine position and a 5 cm longitudinal segment of the right brachial artery 4 cm above the antecubital fossa was scanned to obtain continuous two-dimensional and M-mode images. The depth and gain settings were adjusted using a resolution box function to optimize the vessel wall-lumen interface. Electronic calipers were used to measure brachial artery diameter as the distance from the near (anterior) to the far (posterior) walls coincident with the R wave on the simultaneously recorded echocardiogram. Three diameter measurements were made from three different cardiac cycles and averaged. For blood flow measurements, pulsedwave Doppler was used with a Doppler angle of 601 and range gate in the centre of the lumen; an average of three consecutive time velocity integrals was recorded. Volumetric flow rates were calculated by multiplying the time velocity integral of the anglecorrected Doppler flow signal by the heart rate and mean cross-sectional vessel area.
After baseline diameter and flow measurements were obtained, a BP cuff was placed on the forearm and inflated to 50 mm Hg above the subject's SBP (or to 200 mm Hg if SBP was o150 mm Hg) for a period of 5 min. The cuff was then deflated, and blood flow velocity was measured at 15 s after cuff deflation and diameter at 45-90 s after deflation. FMD was calculated as the maximal percent increase in diameter from baseline during the first 90 s after the release of cuff occlusion. The increase in brachial blood flow was calculated as maximum flow recorded in the first 15 s after cuff deflation and expressed as a percent increase from baseline. In 342 subjects, nitroglycerin-mediated dilatation (NMD) was measured as follows. After a 10 min interval, three additional baseline measurements of diameter and flow were obtained and 0.4 mg of sublingual nitroglycerin administered. Four minutes later, the measurements of diameter and flow were repeated. NMD was calculated as the percent increase in diameter after nitroglycerin administration. More than 95% of the brachial artery measurements were performed by a single trained technician who was unaware of the clinical characteristics of the participants or their UACR results.
Statistical methods
Descriptive statistics are expressed as mean7s.d. (as well as median and quartiles) for continuous variables or as frequency (percent) for categorical variables. We used population-based generalized estimating equations (GEE) to account for intrafamilial correlations in the relationships between independent and dependant variables. 21 Because the distribution of FMD was positively skewed, this variable was log transformed after adding 3 to avoid taking log on negative numbers. We plotted the distribution of transformed FMD and NMD in quartiles of UACR. For linear regression analyses, the values of UACR were log transformed after adding 0.1 to reduce skewness (because not all subjects had detectable urine albumin). One-to-one associations of coronary heart disease (CHD) risk factors (age, sex, SBP, diabetes, history of smoking, total cholesterol, HDL cholesterol, BMI), serum creatinine, statin and hypertension medication use and log (UACR þ 0.1) with measures of brachial artery vasoreactivity (FMD and NMD), were tested in simple linear GEE models. We then fitted separate backward elimination multivariable linear GEE models after adjusting for CHD risk factors, serum creatinine and statin and hypertension medication use to determine whether UACR was independently associated with FMD and NMD.
As both diabetes and renal insufficiency have been associated with increased urinary albumin excretion and impaired vascular function, we performed separate sets of secondary analyses in non-diabetic subjects after excluding subjects with renal insufficiency (estimated GFR o60 ml/min). Finally, we assessed whether the association of UACR with FMD and NMD was independent of the class of hypertension medication (beta blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, diuretics and calcium channel blockers) used by including each class of hypertension medications as a covariate, one-at-a-time, in the final regression models for FMD and NMD.
Statistical analyses were performed with statistical analysis software (SAS) v 8.2 (SAS Institute, Cary, NC, USA). A two-sided P-value of o0.05 was considered statistically significant.
Results
Of the 470 subjects, 41% were men, 17% had diabetes and 46% reported history of smoking; nearly one-third of the subjects were on statins. Urinary albumin was detectable in nearly 85% of subjects with about 4.6% having microalbuminuria (UACR 30-300 mg/gm). Estimated GFR o60 ml/min was noted in 41% of the subjects (Table 1) .
Brachial artery FMD was lower with increasing quartiles of UACR (P ¼ 0.032; Figure 1 ). In univariable regression analyses variables associated with lower brachial artery FMD (Po0.10) included age, male sex, history of smoking, lower HDL cholesterol, higher serum creatinine and a higher log (UACR þ 0.1). In stepwise multivariable regression analyses, greater age, male sex and higher log (UACR þ 0.1) were independently associated (Po0.05) with lower FMD whereas statin use was independently associated with higher FMD (Table 2 ).
Brachial artery NMD was lower with increasing quartiles of UACR (Po0.001; Figure 1) . In univariable regression analyses, greater age, male sex, higher SBP, lower HDL cholesterol, higher serum creatinine and higher log (UACR þ 1) were associated (Po0.10) with lower brachial artery NMD. In stepwise multivariable regression analyses, greater age, male sex, higher SBP and a higher log (UACR þ 1) were independently associated (Po0.05) with lower NMD whereas smoking history was associated with higher NMD (Table 3) . When analyses were repeated after excluding the subjects who were not current smokers, the association of smoking history with NMD was not significant (P ¼ 0.09).
In the secondary analyses limited to non-diabetic subjects, higher log (UACR þ 1) was inversely associated with lower FMD (b7s.e. À0.042, P ¼ 0.014) and lower NMD (b7s.e. À0.959, P ¼ 0.0003). When analyses were repeated after excluding the 191 (40.6%) subjects with estimated GFR o60 ml/ min, the association of log (UACR þ 1) with NMD persisted (P ¼ 0.027) whereas that with FMD was not significant (P ¼ 0.23).
Among the hypertension medication classes, the use of calcium channel blockers showed a borderline significant inverse association with NMD (P ¼ 0.034) but not FMD (P ¼ 0.11). Use of other hypertension medication classes (beta blockers, renin-angiotensin system antagonists (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) and diuretics) was not associated with FMD or NMD. Further, the association of log (UACR þ 0.1) with FMD and NMD was independent of the class of hypertension medication the patient was taking (Table 4) .
Discussion
The main finding of the present study is that in hypertensive adults without prior history of myocardial infarction or stroke, increased urine albumin excretion was (inversely) associated with brachial artery vasodilatation in response to increased blood flow (FMD) and to an exogenous vasodilator, nitroglycerin (NMD). The association was significant even after adjustment for SBP and other CV risk factors, indicating thereby that increased urinary albumin in hypertensive adults is an independent marker of vascular dysfunction.
The mechanisms underlying increased urinary albumin excretion in hypertension are incompletely understood. The traditional explanation has been that increased transmission of systemic arterial pressure to the glomerular capillary network leads to leakage of excessive amounts of albumin across the glomerular capillaries, thus 'saturating' the tubular reclamation processes. 22 An alternative explanation is that the appearance of intact albumin molecules in urine results from reduced functionality of the retrieval and/or lysosomal degradative pathways in the proximal tubule. 23 Recently, it has been proposed that microalbuminuria results from excessive glomerular capillary leakage of albumin owing to endothelial dysfunction. This leakage may be worsened by factors such as hyperinsulinaemia and increased renin-angiotensin and sympathetic nervous system activities. 24, 25 The results of our study support such a mechanism, by showing an association between albuminuria and impaired brachial artery reactivity. The present study is the first to demonstrate an association between urinary albumin excretion and impaired brachial artery FMD and NMD in a large sample of hypertensive subjects, independent of CHD risk factors and other variables known to be associated with conduit artery reactivity. As FMD primarily results from the endothelial release of nitric oxide (NO), 26 the inverse association between UACR and FMD indicates that increased urinary albumin excretion in hypertensive individuals may be a manifestation of systemic endothelial dysfunction. Previous studies investigating the relationship between urinary albumin excretion and FMD have yielded conflicting results, with some showing a significant association [27] [28] [29] [30] [31] and others showing no such association. [32] [33] [34] The reasons for these divergent observations are not clear, although methodological differences between various studies could contribute. Further, the inclusion of normotensive individuals in these studies makes direct comparison with the present study difficult. In patients with essential hypertension, increased urinary albumin excretion has been found to be associated with impaired peripheral vasoreactivity to endothelial agonists like acetylcholine, 35 as well as with circulating biomarkers of endothelial dysfunction. 36 The finding of an inverse association between UACR and NMD indicates that increased urinary albumin excretion in hypertensive subjects may be a marker of arterial smooth muscle hyporeactivity to exogenous sources of NO. Several previous studies 27, 28, 31, 37 have reported significantly lower NMD in microalbuminuric than in normoalbuminuric patients; however, the subjects in these studies were mostly normotensive diabetics and non-diabetics. Vasodilatation owing to nitroglycerin involves Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FMD, flow-mediated dilatation; HDL, high-density lipoprotein; SBP, systolic blood pressure; UACR, urinary albumin/creatinine ratio. The multivariable model was built by including all the listed predictor variables at the outset and then removing one-at-a-time until all the remaining variables were significant at Po0.1. Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FMD, flow-mediated dilatation; HDL, high-density lipoprotein; NMD, nitroglycerin-mediated dilatation; SBP, systolic blood pressure; UACR, urinary albumin/creatinine ratio. The multivariable model was built by including all the listed predictor variables at the outset and then removing one-at-a-time until all the remaining variables were significant at Po0.1.
conversion of nitroglycerin to NO within the arterial smooth muscle cell and may be a marker of functional integrity of arterial smooth muscle. 38 Impaired NMD has been noted in the presence of CHD 39 and CHD risk factors 40 including hypertension. 41 In addition, impaired coronary artery vasodilatation to nitroglycerin has been found to be predictive of adverse cardiovascular events. 42 The basis for arterial smooth muscle dysfunction in the presence of hypertension or other cardiovascular risk factors is not known and likely does not involve structural alterations in the smooth muscle because vasoconstrictor response has been found to be preserved in the presence of impaired NMD. 42 Our findings suggest that increased urinary albumin excretion is associated with abnormalities in both 'endothelium-independent' and 'endothelium-dependant' peripheral vascular reactivity in hypertensive individuals. Abnormal peripheral vasoreactivity may be a marker for abnormal renal vascular function, 43, 44 contributing to increased urinary albumin excretion in these subjects. A role for inflammation as a mechanistic link between microalbuminuria and vascular dysfunction has also been proposed. 35, 45 Regardless of the mechanism involved, the present finding of an association between abnormalities in brachial artery (a 'peripheral' conduit artery) function and urinary albumin excretion underscores the generalized nature of vascular dysfunction in persons with essential hypertension.
Almost all (98%) of study participants were on BP-lowering medications, and these medications could have affected brachial artery reactivity and/or urinary albumin excretion. We attempted to minimize the impact of any acute vascular effect of these medications by performing brachial artery ultrasound 12-24 h off of any medications, although Gokce et al. 46 found that recent administration of vasoactive drugs (other than nitrates) had no significant effect on FMD. We did not find chronic use of beta blockers, renin-angiotensin antagonists (angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists) or diuretics to be associated with either FMD or NMD. The only significant association in the present study of an antihypertensive agent with a measure of brachial vasoreactivity was the inverse association between the use of calcium channel blockers and NMD. Whether this reflects the antagonistic effects of the two classes of drugs (calcium channel blockers and nitroglycerin) on arterial smooth muscle is not known, but more importantly, calcium channel blockers use did not influence the inverse association noted between UACR and either FMD or NMD. As the present study was not powered to assess the impact of individual agents from different classes of hypertension medications separately, we cannot rule out the possibility that an association may exist between individual antihypertensive agents and FMD and/or NMD.
A strength of the present study is its relatively large sample size and inclusion of asymptomatic hypertensive individuals drawn directly from the community. The study participants were nonHispanic whites, and the results may not be generalizable to other ethnic groups. Brachial artery measures were assessed a median of B28 months after the UACR determination and collection of risk factor data. Such a temporal gap could have weakened the association between UACR and measures of brachial reactivity.
In conclusion, in a cohort of hypertensive adults from the community, increased urinary albumin excretion was associated with impaired brachial Abbreviations: FMD, flow-mediated dilatation; NMD, nitroglycerin-mediated dilatation; RAS, renin-angiotensin system; SBP, systolic blood pressure; UACR, urinary albumin/creatinine ratio. The variables 'calcium channel blocker', 'beta blocker', 'RAS antagonist' and 'diuretics' were added, one-at-a-time, to the stepwise multivariable models in Tables 2 and 3 for log (FMD+3) and NMD, respectively. Only the final models for 'calcium channel blockers' are shown. Associations of co-variates with log (FMD+3) and NMD were similar when other hypertension medication classes were induced in the models and summaries are confined to the medication class of interest in these models.
artery dilatation in response to increased blood flow and nitroglycerin. Our observations suggest that increased urinary albumin excretion is a marker of functional arterial abnormalities in hypertensive individuals. Such an association may be one of the mechanisms underlying increased CV risk in the setting of increased urinary albumin excretion.
